HAI Pathogens and Antimicrobial Resistance Report Data Tables, 2018-2021

Pediatric Data Tables

PAGE 10 of 11

View Table of Contents

Table P9. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, Pediatrics, 2018-2021

Table P9. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, Pediatrics, 2018-2021
  All Reporting Facilities and Locations
   Pathogen, Antimicrobial Phenotype # Reported % Tested %R
Urgent Threats Acinetobacter spp. 8
Carbapenem-NS . .
Select Enterobacterales2 796
Carbapenem-resistant (CRE) 76.1 1.0
Serious Threats Select Enterobacterales3 689
Extended-spectrum cephalosporin-NS 89.8 27.6
Enterobacter spp. 99
Cefepime-NS 78.8 16.7
Enterococcus faecalis 195
Vancomycin-resistant (VRE) 85.6 1.2
Enterococcus faecium 28
Vancomycin-resistant (VRE) 85.7 29.2
Pseudomonas aeruginosa 328
Multidrug-resistant (MDR) 92.7 5.3
Staphylococcus aureus 32
Meth/ox/cefox – resistant (MRSA) 87.5 50.0

Note: Percent resistance is not calculated when the number of tested isolates is < 20. Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.

Footnotes:

  1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance [PDF – 10.7 MB]
  2. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.
  3. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.